Explore
Validate
LearnDM1200
antibody from Acris Antibodies GmbH
Targeting: ICOSLG
B7-H2, B7h, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653
ELISA
Flow cytometryAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- DM1200 - Provider product page
- Provider
- Acris Antibodies GmbH
- Proper citation
- Acris Antibodies GmbH Cat#DM1200, RRID:AB_973110
- Product name
- anti CD275 / ICOS Ligand
- Antibody type
- Monoclonal
- Antigen
- Genetic immunisation with cDNA encoding Human ICOSL (Extracellular Domain).
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- GM13C1
- Vial size
- 0.1 mg
- Concentration
- 1.0 mg/ml
Submitted references Tumor necrosis factor-alpha regulates the expression of inducible costimulator receptor ligand on CD34(+) progenitor cells during differentiation into antigen presenting cells.
Richter G, Hayden-Ledbetter M, Irgang M, Ledbetter JA, Westermann J, Körner I, Daemen K, Clark EA, Aicher A, Pezzutto A
The Journal of biological chemistry 2001 Dec 7;276(49):45686-93
The Journal of biological chemistry 2001 Dec 7;276(49):45686-93
No comments: Submit comment
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Fig.1: FACS analysis of BOSC23 cells using GM-13C1 Cat.DM1200. BOSC23 cells were transiently transfected with anexpression vector encoding either ICOSL (red curve) or anirrelevant protein (control transfectant: black curve). Binding ofGM-13C1 was detected with a PE-conjugated secondaryantibody. A positive signal was obtained only with ICOSL trans-fected cells.
